Annual Clinical Trials in Oncology East Coast
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Annual Clinical Trials in Oncology East Coast — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Annual Clinical Trials in Oncology East Coast (15th Annual) 2026
Annual Clinical Trials in Oncology East Coast 2026 is an executive-focused, two-day conference designed to help oncology trial teams run studies more smoothly, efficiently, and within budget—while improving the patient experience. The event brings together senior leaders from oncology pharma and biotech organizations from across the East Coast, alongside technology providers, CROs, and patient advocacy groups.
The 15th edition of the conference will take place in Boston, USA at the Boston Marriott Burlington on June 30 – July 1, 2026.
What the event covers for 2026
The program is built around practical, operational strategies for oncology clinical trials. It focuses on the day-to-day challenges that impact execution quality and outcomes, including how teams can strengthen site relationships, advance data management strategies, and stay aligned with evolving US regulatory requirements.
Attendees also explore how modern approaches and new capabilities can improve how oncology trials are delivered. This includes a dedicated new track for 2026: Patient Journey, Tech and Innovation. This track examines how artificial intelligence and emerging technologies can transform patient engagement, streamline processes, and improve trial outcomes—from recruitment through to retention.
Format and learning outcomes
Throughout the conference, attendees participate in expert-led presentations, real-world case studies, and interactive discussions. The goal is to deliver actionable insights and meaningful connections that support continuous improvement in oncology trial excellence and operational performance.
Who attends
This conference is positioned as a meeting place for leading pharmaceutical companies and biotechnology institutes, with participation from senior operational and regulatory decision-makers in oncology clinical development, as well as supporting stakeholders across the clinical research ecosystem (including CROs, technology providers, and patient advocacy groups).
Event scale (as stated by the organizers)
- 150+ attendees
- 20+ exhibitors
- 35+ speakers
Why attend?
Attendees come to optimize oncology trial operations, improve efficiency and budget management, and enhance patient experience. The event also supports networking and collaboration that can help build longer-term relationships across sponsor organizations and solution providers.
Join us for two days of learning, networking, and collaboration in Boston.
Data sheet
| Event Name | 15th Annual Clinical Trials in Oncology East Coast 2026 |
| Event Date | 30 Jun 2026 – 1 Jul 2026 |
| Event Status | Upcoming |
| Venue | Boston Marriott Burlington |
| City | Boston |
| State / Region | Boston |
| Country | United States |
| Organizer | Arena International |
| Official Event Website | arena-international.com/event/oncologyeastcoast/ |
| Event Type | Executive conference / clinical trials summit |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research, IT & Technology, Business Services |
| Audience Reach | Regional with national draw; specialized oncology clinical-trial audience |
| Estimated Attendance / Expected Footfall | 150+ attendees (official organizer figure) |
| Attendance Data Reliability | Confirmed by organizer on official event page |
| Main Purpose of Event | To help oncology trial teams improve execution, control budgets, strengthen site relationships, advance data management, and keep pace with US regulatory requirements. |
Annual Clinical Trials in Oncology East Coast is an executive-level oncology operations conference focused on the practical realities of planning, running, and optimizing clinical trials. The 2026 program emphasizes execution quality, cost control, patient experience, data strategy, and regulatory alignment, with a dedicated track on Patient Journey, Tech and Innovation.
The event is positioned as a highly focused networking and knowledge-sharing platform for senior leaders in oncology pharma and biotech, as well as technology providers, CROs, and patient advocacy groups. For B2B prospecting, it is especially relevant to suppliers supporting clinical operations, trial technology, data management, patient engagement, site enablement, and regulatory workflows.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical Operations Leaders | Pharma, biotech, oncology R&D companies | Own trial execution and vendor selection | High-value buyers for trial operations, software, services, and support tools |
| Procurement and Strategic Sourcing Teams | Life sciences enterprises, CROs | Source clinical vendors and negotiate contracts | Directly relevant for supplier discovery and category management |
| Clinical Trial Operations / Trial Managers | Sponsor companies, CROs | Influence site selection, timelines, and vendor use | Strong fit for operations tools, data platforms, and service providers |
| Regulatory Affairs Leaders | Pharma, biotech, government agencies | Guide compliance and submission strategy | Relevant for compliance software, consulting, and documentation services |
| Data Management and Clinical Informatics Teams | Sponsors, CROs, technology vendors | Select systems and data workflows | Key buyers for analytics, EDC, eCOA, integration, and AI tools |
| Technology and Innovation Leaders | Digital health, trial tech, pharma innovation teams | Pilot and approve new platforms | High relevance for AI, automation, patient engagement, and workflow tools |
| Medical Affairs / Clinical Development Leaders | Oncology pharma and biotech | Shape trial strategy and endpoints | Relevant for consulting, services, and specialized technology providers |
| Patient Engagement / Patient Advocacy Functions | Sponsors, patient support groups, nonprofits | Influence recruitment, retention, and patient support | Relevant for patient support platforms, communication tools, and recruitment services |
| CRO Leadership | Contract research organizations | Manage outsourced trial operations and vendor ecosystems | Strong buyers for services, software, and operational support |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Boston metro area | High | Strong concentration of life sciences, hospitals, CROs, universities, and biotech firms |
| Host state / region | Massachusetts / New England | High | Dense oncology and clinical research ecosystem |
| Nearby business hubs | Cambridge, Waltham, Burlington, Providence, Hartford, New York | High | Accessible for East Coast sponsor and CRO teams |
| National reach | US oncology pharmaceutical, biotech, CRO, and vendor community | High | Specialized topic attracts national decision-makers |
| International reach | Limited but possible for multinational pharma and biotech stakeholders | Medium | Best described as US-focused with selective international participation |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Primary Reach | Regional | Organizer positions the event as East Coast-focused, with Boston as a major life sciences hub. |
| Secondary Reach | National | The oncology clinical-trials topic and executive audience make it relevant to US-wide sponsor, biotech, and CRO decision-makers. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Menarini Stemline | Oncology pharma | Featured speaker organization; active oncology development and regulatory stakeholders. | menarinistemline.com | VP Regulatory Affairs, Clinical Operations Director, Trial Manager | Confirmed Speaker Organization |
| Novartis Oncology | Global pharma | Featured speaker organization; major oncology clinical development buyer. | novartis.com | Senior Medical Director, Clinical Operations Lead, Procurement Manager | Confirmed Speaker Organization |
| Cellectar Biosciences | Biotech | Featured speaker organization; likely to evaluate trial operations and enabling technology/services. | cellectar.com | COO, Clinical Development Director, Program Manager | Confirmed Speaker Organization |
| U.S. Food and Drug Administration (FDA) | Government / regulator | Speaker background indicates regulatory expertise is central to the event. | fda.gov | Clinical Reviewer, Regulatory Policy Lead, Program Manager | Confirmed Speaker Organization |
| IBSA Institut Biochimique SA | Pharma | Organizational testimonial confirms networking relevance for life sciences participants. | ibsa.com | Clinical Operations Director, Business Development Director, Sourcing Lead | Historical / prior-year evidence |
| Medigene AG | Biotech | Organizational testimonial confirms practical networking value. | medigene.com | Clinical Operations Lead, Regulatory Affairs Manager, Partnerships Director | Historical / prior-year evidence |
| AstraZeneca | Global pharma | Previously referenced in speaker biography; major oncology trial sponsor. | astrazeneca.com | Clinical Development Director, Regulatory Affairs Director, Procurement Lead | Historical / prior-year evidence |
| Bristol Myers Squibb | Global pharma | Strong oncology sponsor profile and likely attendee fit for clinical operations and regulatory functions. | bms.com | VP Clinical Operations, Director Procurement, Head of Oncology Development | Strong Market Fit, Attendance Not Confirmed |
| Merck & Co., Inc. | Global pharma | Large oncology portfolio; likely fit for trial operations and sourcing audiences. | merck.com | Clinical Program Director, Procurement Manager, Regulatory Lead | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Global pharma | Major clinical-trial sponsor with oncology operations and vendor management needs. | pfizer.com | Clinical Operations Manager, Strategic Sourcing Director, Trial Technology Lead | Strong Market Fit, Attendance Not Confirmed |
| Roche / Genentech | Global pharma / biotech | Highly relevant for oncology development, patient journey, and clinical operations innovation. | roche.com / gene.com | Director Clinical Operations, Regulatory Affairs, Digital Health Lead | Strong Market Fit, Attendance Not Confirmed |
| Eli Lilly and Company | Global pharma | Large R&D and clinical operations footprint; likely relevant for trial execution solutions. | lilly.com | Clinical Trial Manager, Procurement Director, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Takeda | Global pharma | Relevant sponsor for clinical operations, vendor services, and regulatory-aligned trial support. | takeda.com | Director Clinical Operations, Strategic Sourcing, Regulatory Affairs Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Vice President, Clinical Operations | Clinical Development | VP | Owns trial execution, vendor selection, and operational strategy. |
| 2 | Director of Clinical Operations | Clinical Operations | Director | Manages sites, timelines, and day-to-day study delivery. |
| 3 | Chief Medical Officer | Executive / Medical | C-level | Influences development priorities, endpoints, and clinical strategy. |
| 4 | Vice President, Regulatory Affairs | Regulatory | VP | Key stakeholder for compliance, submission planning, and risk management. |
| 5 | Director of Clinical Trial Operations | Clinical Operations | Director | Evaluates trial efficiency tools and service providers. |
| 6 | Strategic Sourcing Manager | Procurement | Manager | Sources CROs, tech, and service vendors. |
| 7 | Clinical Data Manager | Data Management | Manager / Senior Manager | Strong interest in EDC, analytics, and data quality tools. |
| 8 | Patient Engagement Lead | Patient Access / Clinical Ops | Manager / Director | Relevant for recruitment, retention, and communication solutions. |
| 9 | Program Manager, Oncology Development | Development Operations | Manager | Coordinates cross-functional workstreams and timelines. |
| 10 | Director, Trial Technology / Digital Health | IT / Innovation | Director | Evaluates AI, automation, and patient journey tools. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core sponsor audience for oncology trials. | Clinical ops, sourcing, and regulatory decision-makers |
| 2 | Biotechnology | Strong fit for innovative oncology programs. | Program leaders, clinical operations, partnerships |
| 3 | Medical Devices | Relevant where trial technology, diagnostics, or companion tools are involved. | Clinical affairs and innovation teams |
| 4 | Hospital & Health Care | Site-side and patient care stakeholders can be present. | Research site leaders and operations teams |
| 5 | Research | Clinical research organizations and research enterprises are central. | R&D operations and research services |
| 6 | Information Technology & Services | Relevant for trial tech, analytics, and integration vendors. | Technology buyers and transformation leaders |
| 7 | Information Technology & Services | Useful for software providers supporting trial operations. | IT, digital, and AI solution buyers |
| 8 | Management Consulting | Advisory and transformation support relevant to trial operations. | Strategy and process improvement stakeholders |
| 9 | Market Research | Useful for patient insights and trial design support. | Insights, analytics, and patient journey teams |
| 10 | Event Services | Relevant for sponsors, booth support, and event-participation vendors. | Partnership and marketing leaders |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 150+ | Confirmed | Official event page | Organizer-stated figure |
| Exhibitor count | 20+ | Confirmed | Official event page | Listed on event site |
| Speaker count | 35+ | Confirmed | Official event page | Listed on event site |
| Buyer count | Not publicly confirmed | Not confirmed | Organizer did not publish a buyer-only count | Use attendee-title targeting instead |
| Sponsor count | 2026 sponsors page present; count not extracted | Partially confirmed | Official site navigation | No public numeric count in provided text |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical operations | Improve study execution and milestone delivery | Operational efficiency and ROI discussion | Clinical ops software, managed services, consulting |
| Regulatory compliance | Keep pace with evolving US requirements | Compliance and risk-reduction messaging | Regulatory services, documentation platforms |
| Data management | Improve data quality and integration | Workflow and analytics demos | EDC, data integration, dashboards, AI analytics |
| Patient engagement | Recruitment and retention improvement | Patient journey and retention value proposition | Engagement platforms, reminders, communications |
| Site relationships | Strengthen sites and investigator networks | Trust-building and site enablement outreach | Site support services, portals, training |
| AI and innovation | Explore automation and predictive capabilities | Innovation-focused demos and pilots | AI tools, automation, patient journey tech |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Audience is explicitly senior oncology pharma, biotech, CRO, and patient-focused stakeholders. |
| Decision-maker availability | High | Executive-focused conference with VP, director, and senior leadership presence. |
| Data collection potential | Medium | Confirmed speaker and high-level attendee type data is available; complete current attendee list is not public. |
| Apollo targeting potential | Very High | Clear alignment on pharma, biotech, CRO, healthcare, and technology buyer profiles. |
| Geographic targeting potential | High | East Coast and Boston life sciences cluster provide a focused prospecting geography. |
| Best outreach approach | High-touch, role-based messaging | Use pain-point messaging on speed, compliance, patient engagement, and trial efficiency. |
| Overall lead quality | Very High | Strong fit for event data sales, attendee list sales, and oncology-focused B2B outreach. |
| Best use case | Lead generation and account-based outreach | Ideal for clinical trial service providers, software vendors, CROs, and consulting firms. |
| Limitations / risks | Partial public visibility | No full current-year attendee list was provided in the source text, so some buyer targets are market-fit based rather than confirmed attendees. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals, Biotechnology, Medical Devices, Hospital & Health Care, Information Technology & Services, Research, Management Consulting | Focus on sponsor, CRO, site, and enabling technology buyers |
| Departments | Clinical Operations, Procurement, Regulatory, Medical Affairs, IT, Data, Program Management | Targets the teams most likely to buy or influence purchasing |
| Seniority | Director, VP, CXO, Head, Senior Manager | Prioritize decision-makers and budget holders |
| Job titles | VP Clinical Operations, Director Clinical Operations, Regulatory Affairs Director, Strategic Sourcing Manager, Clinical Data Manager, Trial Technology Lead, Program Manager, Patient Engagement Lead | Direct role targeting for outreach and list building |
| Geography | United States; priority states in East Coast and New England | Align with event’s regional concentration |
| Employee size | 51-200, 201-500, 501-1000, 1000+ | Captures biotech scale-ups through large pharma enterprises |
| Keywords | oncology, clinical trials, clinical operations, patient engagement, data management, regulatory affairs, CRO, site management, AI, trial technology | Improves relevance for event-intent and functional-fit searches |
| Company type | Private, public, enterprise, nonprofit research organizations | Covers sponsor, research, and site-side stakeholders |
Suggested Apollo Search Logic: (oncology OR clinical trials OR clinical operations OR regulatory affairs OR patient engagement OR trial technology) AND (pharmaceuticals OR biotechnology OR CRO OR hospital) AND (Director OR VP OR Head OR Senior Manager OR C-level) AND geography: United States, East Coast.
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Arena International – 15th Annual Clinical Trials in Oncology East Coast 2026 | Official organizer event page | Event name, dates, venue, city, audience positioning, attendee categories, speaker examples, attendance figures | High |
| Arena International Home Page | Organizer website | Organizer profile, healthcare event portfolio, B2B event positioning | High |
| Official event page speaker section | Official agenda / speaker information | Verified speaker organizations including Menarini Stemline, Novartis Oncology, Cellectar Biosciences, FDA | High |
| Official event page “What to Expect for 2026” section | Official description | Confirmed attendance estimate, exhibitor and speaker counts | High |
| Official event page testimonials | Historical attendee evidence | Prior participation signal from IBSA Institut Biochimique SA and Medigene AG | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Annual Clinical Trials in Oncology East Coast — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.